How Lung Cancer Screening Habits Relate to Stage at Diagnosis
Studies how people's screening habits relate to lung cancer found early.
Key facts
- Who runs it
- Fudan University
- Where
- Shanghai, ChinaSee the site
- Trial code
- Registry title
- Association Between Screening Behaviors and Lung Cancer Spectrum
- Status
- Recruiting
- People taking part
- 5,390 people, planned
- Started
- 14 May 2026
- Expected to end
- 1 Jun 2027
- Type of study
- Observational
- Record updated
- 4 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults newly diagnosed with primary lung cancer in the past year. They must be able to give their health and check-up history from before the diagnosis.
- Sex
- All sexes can join.
- Disease stage
- Primary lung cancer confirmed by tissue test (surgery or biopsy) within the past year.
Main reasons for not taking part
- Lung cancer that came back (recurrent) or tumors that spread to the lung from elsewhere
- Missing key medical data, such as cancer type or stage
- Memory or thinking problems, or severe mental illness, that make it impossible to fill in the questionnaire
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Histologically confirmed primary lung cancer within the past year (surgical or biopsy pathology)
- Patients capable of clearly recalling or providing medical and physical examination history prior to diagnosis
Who cannot take part
- Recurrent lung cancer or metastatic lung tumors
- Patients with cognitive impairment or severe mental illness who cannot cooperate with the questionnaire
- Severe lack of critical clinical data (e.g., inability to provide pathological type or stage)
Where in China
- Fudan University Cancer CenterShanghai, ChinaContact: Chen Haiquan, MDTaking people
About the trial
What the trial wants to find out
The goal of this observational study is to describe the clinical epidemiological characteristics and disease spectrum distribution of newly diagnosed primary lung cancer patients in a real-world setting. The main questions it aims to answer are:
Read full original descriptionShow less
What is the current status of lung cancer epidemiology, including age, gender, smoking history, and pathological subtype distribution? How do different lung cancer screening behaviors (e.g., overscreening, underscreening, guideline-concordant, and precision screening) influence the capture rate of the "curative time window" (defined as adenocarcinoma in situ (AIS)/minimally invasive adenocarcinoma (MIA) or pure Ground-Glass Nodules (GGNs) stage)? What are the economic costs and cumulative radiation exposure associated with these different screening patterns? Researchers will compare these screening behavior groups to evaluate the efficacy of the "low-age, low-frequency" screening strategy in capturing early-stage lung cancer.
Participants will be asked to:
Provide their medical history and detailed records of pre-diagnosis lung cancer screening (including CT scan history).
Allow researchers to collect and analyze their clinical, pathological, and radiological data from hospital records and medical databases.
Complete a questionnaire regarding their screening history and health-related behaviors.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Multicenter, Prospective, Observational Study on the Association Between Real-World Lung Cancer Screening Behaviors and Lung Cancer Disease Spectrum
- Plain-language title
- How Lung Cancer Screening Habits Relate to Stage at DiagnosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 4 June 2026